Perceptive Advisors - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2021$56,912,000
+9661.9%
453,520
+6556.7%
0.37%
+2366.7%
Q1 2020$583,000
-98.5%
6,813
-99.2%
0.02%
-99.0%
Q4 2018$39,938,000
-54.3%
905,017
-40.8%
1.52%
-35.0%
Q3 2018$87,459,000
+18.0%
1,528,2050.0%2.34%
+20.3%
Q2 2018$74,149,000
+25.1%
1,528,205
+0.8%
1.94%
+17.0%
Q1 2018$59,286,000
-13.6%
1,516,259
-6.2%
1.66%
-27.0%
Q4 2017$68,594,000
-43.1%
1,616,259
-50.0%
2.27%
-1.3%
Q3 2017$120,638,000
+458.1%
3,232,518
+354.5%
2.30%
+111.7%
Q2 2017$21,615,000
+23.0%
711,259
+7.1%
1.09%
+8.7%
Q1 2017$17,572,000
+11.1%
663,857
+7.1%
1.00%
-11.0%
Q4 2016$15,822,000
-25.9%
619,987
+5.1%
1.12%
-18.4%
Q3 2016$21,348,000
+4.2%
589,890
-2.2%
1.38%
-3.0%
Q2 2016$20,491,000
-3.3%
603,036
-24.9%
1.42%
-23.6%
Q1 2016$21,192,000
+57.4%
803,036
+190.9%
1.86%
+86.6%
Q4 2015$13,460,000
-2.1%
276,036
-50.0%
1.00%
+81.4%
Q3 2015$13,746,000
+57.4%
552,072
+100.0%
0.55%
+4.4%
Q2 2015$8,734,000
-31.7%
276,036
-17.9%
0.53%
-47.1%
Q1 2015$12,790,000
+3.4%
336,036
+5.8%
0.99%
-4.2%
Q4 2014$12,375,000
-8.0%
317,636
-28.6%
1.04%
-28.2%
Q3 2014$13,457,000
+32.0%
445,000
+48.3%
1.44%
+44.5%
Q2 2014$10,191,000300,0001.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 3,133,234$124,076,00082.43%
Deer VII & Co. Ltd. 1,105,964$39,417,0009.51%
Foresite Capital Management I, LLC 66,000$2,614,0002.54%
QVT Financial LP 556,574$21,592,0001.27%
Orbimed Advisors 2,117,648$83,859,0001.23%
SPHERA FUNDS MANAGEMENT LTD. 50,000$1,980,0000.55%
WALL STREET ASSOCIATES 93,800$3,714,0000.30%
DRIEHAUS CAPITAL MANAGEMENT LLC 197,219$7,810,0000.28%
EAM Investors, LLC 37,871$1,500,0000.27%
Granite Point Capital Management, L.P. 30,000$1,188,0000.20%
View complete list of ACCELERON PHARMA INC shareholders